Evidence map›Paper›PMID 39134055›Full record

ReviewInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2024

Therapeutic ultrasound transducer technology and monitoring techniques: a review with clinical examples.

Maxime Lafond, Allison Payne, Cyril Lafon

Abstract readReview
In one paragraph

Review in International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Assessment of Cavitation From DEFINITY and DEFINITY RT.Ultrasound in medicine & biology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maxime LafondLabTAU, INSERM, Centre Léon Bérard, Université, Lyon, France.
Allison PayneDepartment of Radiology and Imaging Sciences, University of UT, Salt Lake City, UT, USA.
Cyril LafonLabTAU, INSERM, Centre Léon Bérard, Université, Lyon, France.

Funding

Validation and translation of a non-invasive, MR-guided breast cancer therapyR37CA224141 · NCI · UNIVERSITY OF UTAH · PI PAYNE, ALLISON · 2018 to 2024
$3.7M
A tissue viability imaging biomarker for use in non-invasive breast cancer therapyR01CA259686 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SARANG JOSHI, Allison Payne · 2022 to 2026
$2.9M
NCI NIH HHS R01 CA259686NCI NIH HHS R37 CA224141
6 · The paper itself

Abstract

The exponential growth of therapeutic ultrasound applications demonstrates the power of the technology to leverage the combinations of transducer technology and treatment monitoring techniques to effectively control the preferred bioeffect to elicit the desired clinical effect.

Indexed as

TransducersUltrasonic TherapyHumansFocused ultrasoundhigh-intensity focused ultrasoundtherapeutic ultrasoundultrasound monitoringultrasound transducer

Identifiers

PMID39134055
PMCPMC11375802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.